Section of Transplant Surgery

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Liver 67%
3. Transplants 59%
4. Allografts 42%
5. Tissue Donors 41%
6. Hepatocellular Carcinoma 39%
7. Kidney 35%
8. Kidney Transplantation 34%
9. Transplant Recipients 30%
10. Survival 25%
11. Transplantation 24%
12. Reperfusion Injury 21%
13. Neoplasms 17%
14. Mitochondrial Transmembrane Permeability-Driven Necrosis 17%
15. Autophagy 17%
16. Hepatocytes 16%
17. Tissue and Organ Procurement 15%
18. Graft Survival 14%
19. Blood Vessels 14%
20. Therapeutics 14%
21. Hepacivirus 13%
22. Pancreas Transplantation 12%
23. Wounds and Injuries 12%
24. Recurrence 12%
25. Living Donors 12%
26. Klatskin Tumor 12%
27. Pancreas 11%
28. Reperfusion 11%
29. Arteriovenous Fistula 11%
30. Fibrosis 11%
31. Pediatrics 11%
32. Organ Transplantation 10%
33. Computer-Assisted Surgery 10%
34. Endothelial Cells 10%
35. Surgeons 10%
36. Swine 10%
37. Cryosurgery 10%
38. Pancreaticoduodenectomy 10%
39. Cholangiocarcinoma 9%
40. T-Lymphocytes 9%
41. Liver Diseases 9%
42. Cyclosporine 9%
43. Ischemia 9%
44. Costs and Cost Analysis 9%
45. Bile Ducts 8%
46. Incidence 8%
47. Renal Dialysis 8%
48. Apoptosis 8%
49. Dialysis 8%
50. End Stage Liver Disease 8%
51. Neoplasm Metastasis 7%
52. Tacrolimus 7%
53. Mortality 7%
54. Pathologic Constriction 7%
55. Immunosuppression 7%
56. Gallstones 7%
57. Cell Death 7%
58. Hemostasis 7%
59. Portal Vein 7%
60. Morbidity 7%
61. Antibodies 7%
62. recombinant human thrombin 6%
63. Lung 6%
64. Hepatitis C 6%
65. Survival Rate 6%
66. Hepatectomy 6%
67. Collagen 6%
68. Drug Therapy 6%
69. Virus Diseases 6%
70. Hemorrhage 6%
71. Gallbladder 6%
72. Positron-Emission Tomography 6%
73. Biopsy 6%
74. Rectal Neoplasms 5%
75. Databases 5%
76. Perfusion 5%
77. Safety 5%
78. Everolimus 5%
79. Warm Ischemia 5%
80. HLA Antigens 5%
81. Length of Stay 5%
82. Sirtuin 1 5%
83. Cold Temperature 5%
84. thymoglobulin 5%
85. Pancreatic Neoplasms 5%
86. Colorectal Neoplasms 5%
87. Economics 5%
88. Acute Liver Failure 5%
89. Hepatic Artery 5%
90. Cytomegalovirus 5%
91. Laparoscopic Cholecystectomy 5%
92. Neoadjuvant Therapy 5%
93. Necrosis 5%
94. Cytokines 5%